Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Inc

170.34
+2.531.51%
Post-market: 170.340.00000.00%18:18 EDT
Volume:545.52K
Turnover:92.82M
Market Cap:20.43B
PE:46.80
High:170.51
Open:168.92
Low:168.79
Close:167.81
Loading ...

PTC Acquires IncQuery Group

MT Newswires Live
·
02 Apr

BRIEF-Ptc Strengthens Alm And Systems Engineering Focus With Acquisition Of Incquery Group

Reuters
·
02 Apr

PTC acquires IncQuery Group

TIPRANKS
·
02 Apr

PTC Strengthens Alm and Systems Engineering Focus With Acquisition of Incquery Group

THOMSON REUTERS
·
02 Apr

PTC Strengthens ALM and Systems Engineering Focus with Acquisition of IncQuery Group

PR Newswire
·
02 Apr

PTC Therapeutics Is Maintained at Overweight by JP Morgan

Dow Jones
·
31 Mar

PTC Therapeutics price target lowered to $75 from $78 at JPMorgan

TIPRANKS
·
31 Mar

PTC Therapeutics (PTCT) Gets a Hold from TD Cowen

TIPRANKS
·
28 Mar

PTC Therapeutics Loses EU Authorization for Translarna in Duchenne Muscular Dystrophy

MT Newswires Live
·
28 Mar

PTC Therapeutics Shares Fall After EU Drops Translarna Authorization

Dow Jones
·
28 Mar

PTC Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
28 Mar

Actelis Networks Secures New Order from One of North America’s Largest Railway Groups for Positive Train Control Implementation

GlobeNewswire
·
27 Mar

BRIEF-PTC Inc Launches Codebeamer 3.0 ALM Solution

Reuters
·
27 Mar

PTC Inc - Launches Codebeamer 3.0 Alm Solution

THOMSON REUTERS
·
27 Mar

PTC Launches Codebeamer 3.0

PR Newswire
·
27 Mar

PTC to Showcase Windchill AI at Hannover Messe 2025: Stock to Gain?

Zacks
·
26 Mar

PTC Brings AI-Powered PLM to Hannover Messe 2025 with Windchill AI

PR Newswire
·
25 Mar

PTC Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
25 Mar

Promising Potential of PTC Therapeutics’ Sepiapterin in PKU Treatment Justifies Buy Rating

TIPRANKS
·
21 Mar

PTC Therapeutics Presents New Sepiapterin Data from Ongoing Studies

PR Newswire
·
20 Mar